[ Price : $8.95]
FDA commissioner Martin Makary says there are no current plans to restrict access to the abortion drug mifepristone.[ Price : $8.95]
Abbott recalls its HeartMate Mobile Power Unit to remove the component due to instances where the device experiences a sudden powe...[ Price : $8.95]
Axios reports that key FDA databases that are relied on by healthcare professionals are not being fully updated due to staff short...[ Price : $8.95]
FDA approves an Akeso Biopharma BLA for penpulimab-kcqx, indicated for adults with recurrent or metastatic non-keratinizing nasoph...[ Price : $8.95]
The Association for Clinical Oncology tells the new leaders of FDA, NIH, and CMS it looks forward to working with them on behalf o...[ Price : $8.95]
Bristol Myers Squib says its Cobenfy showed positive results in the Phase 3 ARISE trial as an adjunctive therapy to atypical antip...[ Price : $8.95]
Former FDA associate commissioner Peter Pitts calls on the agency to revise drug labels with obesity safety and effectiveness info...[ Price : $8.95]
Lilly sues four additional drug compounders for illegally selling copies of its weight loss and diabetes drugs.